Navigation Links
MicroCHIPS Named 2010 Technology Pioneer by World Economic Forum
Date:12/3/2009

BEDFORD, Mass., Dec. 3 /PRNewswire/ -- MicroCHIPS, a developer of intelligent, responsive implant systems, today announced it has been named a 2010 Technology Pioneer by the World Economic Forum.

The company was selected for pioneering a novel medical device platform that uses patented, responsive implants designed to bridge the gap between disease monitoring and treatment. MicroCHIPS' technologies have broad applicability, from 'rescue' applications in diabetes and cardiology, where precise therapy at a critical moment can save a life, to long-term treatment with highly effective drugs, such as bone-building agents for osteoporosis.

"MicroCHIPS' technologies have the potential to couple in-body sensing with the most effective use of potent therapeutics to enable the delivery of the right dose of the right therapy at the right time. This is essential to optimally treat dynamic clinical conditions," explains John Santini, PhD, CEO of MicroCHIPS. "Our vision is to offer patients treatment that is responsive to their particular condition. We are honored to have been awarded the Technology Pioneer distinction by the World Economic Forum."

Technology Pioneers are companies that have been identified as creating and applying highly transformational and innovative technologies. To be selected, a company must be involved in the development of life-changing technology innovation that has the potential for long-term impact on business and society. In addition, selected companies must demonstrate visionary leadership and show all the signs of being long-standing market leaders.

"Entrepreneurship, innovation and technology have always played a key role in shaping and improving society. These companies are planting the seeds of the next wave of growth and progress," said Andre Schneider, Managing Director and Chief Operating Officer of the World Economic Forum.

About MicroCHIPS' Technologies

MicroCHIPS' technologies are being applied to the creation of intelligent in-body devices that can sense vital biochemical changes, deliver potent drug therapies and communicate using wireless technologies. First developed at the Massachusetts Institute of Technology, the technologies use microreservoir arrays to store and protect chemical sensors or potent drugs within the body for extended periods of time. The reservoir arrays are compatible with preprogrammed microprocessors, wireless communications and sensor feedback loops to provide precise, dynamic control of sensor activation and drug release.

About MicroCHIPS

MicroCHIPS, Inc. is pioneering intelligent implanted devices designed to improve the health of millions of people with critical conditions that require careful monitoring and precise therapy. For more information, please visit our Web site at www.mchips.com.

SOURCE MicroCHIPS, Inc.


'/>"/>
SOURCE MicroCHIPS, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Aspirin Named 8th World Wonder by Majority of Americans
2. American Board of Internal Medicine President Named to Alzheimers Study Group
3. New York Infection Prevention Expert Named Recipient of Carole DeMille Award
4. Pharmaxis Establishes Named Patient Program for Bronchitol
5. University of Rochester Researcher Named Millennium Pharmaceuticals Career Development Scholar of The Leukemia & Lymphoma Society
6. Eularis Releases First-Ever Study on ROI of Pre-Launch Named Patient Programmes
7. Battelle Scientists Named on Patent for Making Oxygen From Light and Water
8. Ikaria(R) Named Private Company of the Year by New Jersey Technology Council
9. Cell Therapeutics and IDIS Announce Agreement for a European Named Patient/Compassionate Use Program for Pixantrone
10. Rib-X Pharmaceuticals Novel Antibiotic Delafloxacin Named One of R&D Directions 100 Great Investigational Drugs of 2009
11. EMD Serono, Inc. Named as a Top Employer by Science Magazine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ITL Limited, ( ASX: ITD ), ... für das zum 31. Dezember 2016 endende Halbjahr ... vorlegen zu können. Eine vollständige Präsentation „Ergebnisse von ... Sie hier . Glanzpunkte ... 2015: 1,04 Millionen USD; +104 %) Gewinn je ...
(Date:2/24/2017)... 2017  Directors from Pharma To Market Pty Ltd and Ador ... resulting in the founding of Pharma To Market Pte Ltd, based ... are pleased to announce their expansion into Asia ... . The company are delighted to appoint Joelle Chia ... Singapore based entity. Joelle brings with her an ...
(Date:2/24/2017)... 2017 Non-alcoholic steatohepataitis (NASH) Pipeline ... drugs being developed for the treatment of ... that are in various phases of development ... on novel pharmacologic drugs & regenerative medicines ... recombinant proteins and RNA-based therapeutics, but excludes ...
Breaking Medicine Technology:
(Date:2/24/2017)... ... ... The Smart Machine Age is here, and it’s disrupting everything. Not only could it ... the United States may be taken over by technology in the next five to ... over colleagues is drawing to a close. Success will belong to those who can ...
(Date:2/24/2017)... Viejo, CA (PRWEB) , ... February 24, 2017 , ... ... Final Cut Pro X . Users have total control over position, rotation, distortion, ... and more all within Final Cut Pro X. , With ProGlass Prism users are ...
(Date:2/24/2017)... ... ... The Radiology Business Management Association will select the 2017 ... Building Better Radiology Marketing Programs conference, held this year from March 5 to ... are given out in five categories. They are:, ,     Patient Marketing, ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... Justice jointly issued a letter to withdraw previous guidance issued by ... gender identity. The guidance issued in May 2016 by the Obama Administration came ...
(Date:2/23/2017)... CA (PRWEB) , ... February 23, 2017 , ... Los ... two episodes of WE TV’s “Mama June: From Not to Hot,” which will begin ... notable, “Mama” June Shannon, known to millions from the 2012 reality television series, “Here ...
Breaking Medicine News(10 mins):